Imara (IMRA) Competitor Comparison
We are evaluating the key criteria listed to compare Imara (IMRA) against its competitors in the Biotechnology industry.
Market Capitalization
236 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
114 / 337Free Cashflow
144 / 352Quick Ratio
1 / 357Earnings per Share
41 / 359Dividend yield
0 / 6Total Cash
225 / 358Performance 3 years
173 / 368Performance 5 years
188 / 368Performance 10 years
161 / 368Linearity 3 years
112 / 368Linearity 5 years
145 / 368Linearity 10 years
113 / 368Total Rank
151 / 368Dividend Rank
155 / 368Valuation Rank
11 / 368Piotroski Rank
12 / 368Muliplier Rank
362 / 368Total Rank - IMRA ranking 151 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.